Laval, QC – April 9, 2025 – Corealis Pharma, a premier Contract Development and Manufacturing Organization (CDMO) specializing in solid oral dose formulation development and clinical GMP manufacturing, is pleased to announce its integration into the Science Exchange platform. This strategic collaboration streamlines the procurement and vendor management processes for clients seeking specialized CDMO services, enhancing both efficiency and transparency.
By joining the Science Exchange marketplace, Corealis Pharma becomes even more accessible to a global network of specialty pharmaceutical and biotechnology companies who are seeking a trusted CDMO partner. The platform’s centralized and secure online marketplace enables users to easily initiate proposal requests, align projects, manage communication, and ensure procurement compliance—all in a single easy-to-use interface.
“Corealis Pharma’s presence on Science Exchange marks a significant milestone in connecting with innovative partners across the pharmaceutical value chain,” said David Leroux-Petersen, CEO of Corealis Pharma. “We’re excited to expand and streamline our access and visibility through this powerful, streamlined procurement platform.”
Science Exchange offers a secure and scalable solution for sourcing complex R&D services, allowing users to evaluate providers, negotiate terms, and maintain procurement compliance without administrative hurdles. Through this partnership, clients gain direct access to Corealis Pharma’s comprehensive capabilities in preclinical and clinical-stage stage development, including:
- Preformulation and drug product assessment
- Formulation development
- Analytical method development and validation
- GMP manufacturing for Phase I and II clinical trials.
This integration reinforces Corealis Pharma’s commitment to innovation, quality, and collaborative growth within the global drug development ecosystem.
About Science Exchange
Science Exchange is the world’s leading R&D marketplace, powering innovation by enabling efficient and compliant outsourcing of scientific services. The platform gives scientists and procurement teams access to a global network of pre-qualified providers across every research discipline—streamlining workflows, accelerating timelines, and reducing costs.
About Corealis Pharma
Corealis Pharma is a 20 year-old CDMO that is focused on the formulation development and manufacturing of solid oral dosage forms for the pharmaceutical and biotech industries. With a reputation for technical excellence, agility, and a client-centric approach, Corealis provides a comprehensive suite of services from early-stage formulation to GMP clinical trial material manufacture.
For inquiries, please contact:
Patrick Frankham, VP, Business Development
Corealis Pharma Inc.
Email: patrick.frankham@corealispharma.com
Phone: +1 (450) 973-7505
Website: www.corealispharma.com
Contact Corealis
Corealis’ experts are ready to answer any queries about the company’s oral solid dose offering, including its development and manufacturing capabilities.
